Springer Healthcare Independent Medical Education (IME)’s Post

Test your knowledge and management capabilities in our newly published patient case study simulation! Led by Tina Vosboll, learn how to manage hyperglycemia in your patients with CKD and T2D, including which steps to take when patients don’t respond to first-line therapies. Available at https://lnkd.in/eeen77Gu --- The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs. Supported by an educational grant from NOVO NORDISK A/S. #diabetes #type2diabetes #t2d #chronickindeydisease #ckd #nephrology #medicaleducation #patientsimulation #continuingmedicaleducation #cme #independentmedicaleducation #ime #SpringerIME

Test your knowledge and management capabilities in our newly published patient case study simulation! Led by Nikolaus Marx, practice creating an evidence-based management plan for a multimorbid patient with T2D, CKD and CVD. Available at https://lnkd.in/eTnEbT_N --- The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs. Supported by an educational grant from NOVO NORDISK A/S. #diabetes #type2diabetes #t2d #chronickindeydisease #ckd #nephrology #medicaleducation #patientsimulation #continuingmedicaleducation #cme #independentmedicaleducation #ime #SpringerIME

REGISTER NOW for the upcoming UC San Diego Hot Topics in Medicine virtual course on Chronic Kidney Disease and T2DM.   November 1, 2023 12:15-1:00PM PT   Join Dr. Natalie Sweiss to learn about the care of Chronic Kidney Disease (CKD) patients with and without T2DM including recent progress in preventing progression of CKD.   Topics discussed will include:   ·       Review impact of Chronic Kidney Disease ·       Advancements in Care ·       Best Practices for Clinic ·       Future Directions   The target audience for this course includes nephrologists, primary care providers, advanced practice providers, and specialists interested in learning more about options for treating Chronic Kidney Disease (CKD) patients with and without T2DM in their practices.   FREE REGISTRATION! To register, go to: https://lnkd.in/gHYHFQ8g   #hottopicsinmedicine #nephrology #nephrologists #CKD #kidneydisease #internalmedicine #primarycare #meded #continuingprofessionaldevelopment #cpd  

🔬📊 Exciting new research alert! Our recent paper evaluates the impact of intrathecal recombinant human arylsulfatase A (rhASA) on MRI-assessed brain tissue changes in children with metachromatic leukodystrophy (MLD). 🧠 We collected and analyzed MRI data from a comprehensive cohort, including children receiving intravenous and intrathecal rhASA treatment, untreated MLD cases, and normally developing children. Key findings from our study include: - Structural evidence of neurological deterioration in children with MLD across all assessed imaging parameters compared to healthy normally developing children. - Significant lower gray matter (GM) volume in intravenous versus intrathecal rhASA-treated children, with also steeper decline in volume observed in those receiving low-dose intrathecal treatment compared to high-dose intrathecal treatment. - Positive correlation between GM volume in intrathecal rhASA-treated children and Gross Motor Function Measure scores, suggesting potential therapeutic benefits. - Potential delay in neurological deterioration observed in some children receiving high-dose intrathecal rhASA. Our research sheds light on the potential of intrathecal rhASA therapy in mitigating the progression of MLD, offering hope for improved outcomes and quality of life for affected children. 🌟 Read the full paper https://lnkd.in/e_y-qR7S. Join us in advancing our understanding and treatment of rare neurological disorders! #MLD #NeurologyResearch #IntrathecalTherapy #MRI #ChildHealth #ResearchImpact

Learn how Cedars-Sinai Medical Network designed a comprehensive medication management program that integrated #pharmacists as part of the care team in specialty #neurology clinics which helped improve care access and #migraine control for patients and helped reduce avoidable emergency room visits. "Having a clinical pharmacist in our office has allowed us to see acute migraine patients on the same day, which has saved countless emergency and urgent care visits," said one neurologist at Cedars-Sinai Medical Network. #valuebasedcare #healthinnovation #healthoutcomes Read more: https://lnkd.in/eQVD9Vry

🔬🌟 Trailblazing #Firsts_in_Pharmacology: From Milestones to Medical Marvels! 💊 Today, let's journey back through time to celebrate the #groundbreaking #firsts in the world of #pharmacology-milestones that have shaped modern #medicine and improved countless lives. 🚀 🎯 #First_Local_Anaesthetic - Cocaine: In 1884, Austrian surgeon Carl Koller pioneered local #anaesthesia by introducing #cocaine. This remarkable discovery transformed pain management, enabling #surgical procedures with minimized discomfort. 🧠 #First_Drug for Schizophrenia - Chlorpromazine: French surgeon Henri Laborit's research led to the development of #chlorpromazine in the 1950s, revolutionizing the treatment of #schizophrenia. This marked a transformative step in #psychiatric care. 💙 #First_oral_ACE_Inhibitor - Captopril: In 1975, #pharmacologist Miguel Ondetti and his team developed #captopril, the first oral #ACE #inhibitor. This innovation has since become a cornerstone in managing #hypertension and #heart failure. 🩸 #First_Fibrinolytics - Streptokinase: Swedish physician Ulf von Euler's discovery of #streptokinase in the 1940s paved the way for #fibrinolytic therapy. This class of drugs has revolutionized the treatment of conditions like heart attacks and strokes. 🦠 #First_Antibiotic - Penicillin: The iconic discovery of #penicillin by Alexander Fleming in 1928 marked the birth of #antibiotics. This chance observation revolutionized the treatment of #bacterial infections and set the stage for a new era in medicine. 🌟 Impact on Modern Medicine: These firsts in pharmacology exemplify the power of scientific innovation. They've not only shaped #medical practices but have also paved the way for further discoveries that have saved lives and improved health worldwide. 🔬 Our Ongoing Journey: As professionals in pharmacology, we stand on the shoulders of these pioneers. Our work continues to push boundaries, exploring new compounds, innovative treatments, and novel drug delivery systems. Let's celebrate these firsts as we continue to push the envelope of pharmacology, driving innovation and making strides towards a healthier future for all. 🌱🏥 #PharmacologyFirsts #MedicalMilestones #InnovationInMedicine #ScientificDiscovery #HealthcareInnovations #PharmaceuticalAdvancements #MedicalBreakthroughs

Two-day #course on #upperlimb #rehabilitation after #stroke It was a pleasure to team up with Marc Michielsen from Jessa Ziekenhuis to deliver this course to the team of #neurological #physiotherapy and #occupationaltherapy from Cliniques universitaires Saint-Luc. Thank you to Marie Foucart and Charlotte Pietteur for the invitation and hospitality. In the course, we focus on theory and practice for upper limb rehabilitation including #core activation, proximal stabilisation, #reaching and #grasping. The theoretical components cover also knowledge about interpreting #systematicreviews and meta analyses, randomized controlled trials (#RCT), upper limb #prediction and #guidelines. The practical components provide #knowledge background, #demonstrations and practical sessions with #feedback.

𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗡𝗲𝘄 𝗔𝗹𝗽𝗵𝗮𝗪𝗮𝘃𝗲™ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝘆 𝘁𝗼 𝗯𝗲 𝗽𝘂𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗹𝗼𝗴𝘆 𝗮𝗻𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 A new AlphaWave™ clinical study has now been peer reviewed and approved for publication in Neurology and Therapy. Publication is to be released by 14 May. This study examined the efficacy and safety of AlphaWave™ in a moderately stressed, healthy adult population for 28 days at a dosage of 400mg/day. The study showed participants supplemented with AlphaWave® reported significant improvements in their self-perceived and self-reported stress after 28 days compared to baseline. The results also showed that longer-term supplementation with AlphaWave® was safe and well-tolerated in the studied populations. This latest published study represents another important step in demonstrating a link between daily AlphaWave® L-Theanine supplementation and positive effects on perceived stress and attention in healthy populations. #complementarymedicine #LTheanine #StressRelief #AlphaWave #TransChem

📌 Today the LXXV Annual Meeting of the Sociedad Española de Neurología is held in Valencia, and within the framework of this meeting, the medical department of #BMSIberia has organised an activity with the Spanish Society of Neurological Nursing (SEDENE). 👩⚕️ The aim of the symposium was to highlight the evolution of the role of #nursing in the care of patients with #MultipleSclerosis, where progress has been made in more personalised attention in the comprehensive care of the patient, their adherence and monitoring of the latest therapeutic innovations in #MS. 🤝 At #BMS we are committed to supporting the entire Multiple Sclerosis community, not only through #research into innovative therapies, but also by engaging with them from start to finish. Only in this way is it possible to build a safety net that embraces patients, families, clinicians and organisations. Together, we forge a path to a more hopeful future for all. 🚀 Many thanks to our speakers for their involvement and for enriching us with their knowledge! Miguel Ángel Robles Sánchez, Ana Lozano Blázquez and Noelia Becerril. We would also like to thank all the participants and the #BMSIberia Team who made it possible! Paz Hernanz Hernanz and Daniela Rossi, PhD. #RASEN23 #SEDENE2023 #Neurology #BMSIberia #BMSEspaña #BMSPortugal #BMSCommunity #BMSTransformingLives #WorkingTogetherforPatients #BMSTransformingPatientsLive

🩺 **Prior Authorization for Neurologists: Streamlining the Process** 👩⚕️ Ensuring smooth patient care is crucial for neurologists. A seamless prior authorization process is key to providing timely treatments and interventions for neurological conditions. 🧠 Neurologists often deal with complex cases that require specialized medications, diagnostics, and procedures. Prior authorization helps ensure that these interventions are medically necessary and appropriate for the patient's condition. 💻 When submitting a prior authorization request, neurologists should provide detailed clinical documentation, including the patient's medical history, relevant test results, and treatment plans. Clear communication is essential to justify the need for the requested services. 🕒 Remember that prior authorization can take time, and delays in approval may impact patient care. Neurologists should stay proactive in following up on pending requests and providing any additional information requested by payers promptly. ⚡️ Automation tools and technology can help streamline the prior authorization process for neurologists. Utilizing electronic prior authorization platforms can enhance efficiency and reduce administrative burden. 🌐 If you need Prior Authorization Outsourcing Services, visit our website at 🌐 https://www.staffingly.com 📧 support@staffingly.com 📞 Call Toll Free: (800) 489-5877 📱 SMS/Text : +1(347) 545-7070 #Neurology #PriorAuthorization #HealthcareEfficiency